Effect of therapeutic GAS6/AXL inhibition of tumor and stromal cells on DNA damage and response to chemotherapy in ovarian cancer.

被引:3
|
作者
Mullen, Mary M.
Lomonosova, Elena
Noia, Hollie M.
Guo, Lei
Kuroki, Lindsay Midori
Hagemann, Andrea M.
McCourt, Carolyn K.
Thaker, Premal H.
Mutch, David Gardner
Powell, Matthew A.
Fuh, Katherine Cynthia
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Washington Univ, St Louis, MO 63110 USA
关键词
D O I
10.1200/JCO.2019.37.15_suppl.e14676
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14676
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Targeting the nucleolar DNA damage response as a therapeutic strategy in ovarian cancer
    Sanij, Elaine
    Xuan, Jiachen
    Brajanovski, Natalie
    Kwang, Diannita
    Chan, Keefe
    Beetham, Henry
    Simpson, Kaylene
    Mileshkin, Linda
    Scott, Clare
    Pearson, Richard B.
    CANCER SCIENCE, 2023, 114 : 189 - 189
  • [32] Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 997 - +
  • [33] GAS6 inhibition induces platinum sensitivity through increased replication stress in ovarian cancer
    Mullen, Mary
    Lomonosova, Elena
    Toboni, Michael
    Oplt, Alyssa
    Cybulla, Emliy
    Blachut, Barbara
    Noia, Hollie
    Wilke, Daniel
    Rankin, Erinn
    Kuroki, Lindsay
    Hagemann, Andrea
    Hagemann, Ian
    McCourt, Carolyn
    Thaker, Premal
    Mutch, David
    Powell, Matthew
    Vindigni, Alessandro
    Fuh, Katherine
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S40 - S40
  • [34] Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer
    Akgul, Murat
    Baykan, Ozgur
    Cagman, Zeynep
    Ozyurek, Mustafa
    Tinay, Ilker
    Akbal, Cem
    Uras, Fikriye
    Turkeri, Levent
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2021, 93 (02) : 148 - 152
  • [35] Effect of inhibition of receptor tyrosine kinase AXL by a selective small molecular inhibitor R428 (BGB321) on DNA damage repair response in ovarian cancer cells.
    Huang, Ruby Yun-Ju
    Yeo, Xun Hui
    Tam, Wai Leong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma
    Hedrich, Viola
    Breitenecker, Kristina
    Ortmayr, Gregor
    Pupp, Franziska
    Huber, Heidemarie
    Chen, Doris
    Sahoo, Sarthak
    Jolly, Mohit Kumar
    Mikulits, Wolfgang
    CANCERS, 2023, 15 (09)
  • [37] Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression
    Kong, Lingyu
    Wu, Zhongbing
    Zhao, Yang
    Lu, Xin
    Shi, Huijuan
    Liu, Shugang
    Li, Jing
    BIOSCIENCE REPORTS, 2019, 39
  • [38] DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mirza-Aghazadeh-Attari, Mohammad
    Ostadian, Caspian
    Saei, Amir Ata
    Mihanfar, Ainaz
    Darband, Saber Ghazizadeh
    Sadighparvar, Shirin
    Kaviani, Mojtaba
    Kafil, Hossein Samadi
    Yousefi, Bahman
    Majidinia, Maryam
    DNA REPAIR, 2019, 80 : 59 - 84
  • [39] The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
    Bouberhan, Sara
    Bar-Peled, Liron
    Matoba, Yusuke
    Mazina, Varvara
    Philp, Lauren
    Rueda, Bo R.
    CANCER DRUG RESISTANCE, 2023, 6 (02) : 345 - 357
  • [40] DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer
    Caiola, E.
    Porcu, L.
    Fruscio, R.
    Giuliani, D.
    Milani, R.
    Torri, V.
    Broggini, M.
    Marabese, M.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (02): : 159 - 172